Clinical Trials Browser

LY3023414 × Tumor-Agnostic × Clear all

NCT02632994 2025-09-29

Master Rollover Protocol for Continued Safety Assessment of Study Drug

Neoplasms

NCT02536586 2018-07-24

A Study of LY3023414 in Japanese Participants With Advanced Cancer

Phase 1 Completed

Neoplasms